Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update

PR NewswireOct 31 08:05 ET

Express News | Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for Gavreto® (Pralsetinib)

ReutersOct 24 16:36 ET

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO (Pralsetinib)

PR NewswireOct 24 16:35 ET

Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE

GlobeNewswireOct 16 10:00 ET

Express News | Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for Tavalisse®

ReutersOct 16 10:00 ET

Express News | Rigel Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersOct 4 08:05 ET